# Phase 1 Pharmacokinetics, Safety, and Tolerability Study

> **NCT04067947** · PHASE1 · COMPLETED · sponsor: **Xgene Pharmaceutical Group** · enrollment: 64 (actual)

## Conditions studied

- Pain

## Interventions

- **DRUG:** XG005
- **DRUG:** Placebos

## Key facts

- **NCT ID:** NCT04067947
- **Lead sponsor:** Xgene Pharmaceutical Group
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-07-08
- **Primary completion:** 2019-12-03
- **Final completion:** 2020-02-10
- **Target enrollment:** 64 (ACTUAL)
- **Last updated:** 2020-02-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04067947

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04067947, "Phase 1 Pharmacokinetics, Safety, and Tolerability Study". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT04067947. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*